REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,978,900 | -54.7% | 870,000 | 0.0% | 0.22% | -53.2% |
Q2 2023 | $22,019,700 | +50.7% | 870,000 | -3.3% | 0.47% | +0.9% |
Q4 2019 | $14,607,000 | -59.1% | 900,000 | -10.0% | 0.47% | -66.9% |
Q4 2017 | $35,750,000 | +309.9% | 1,000,000 | +289.9% | 1.41% | +300.9% |
Q2 2014 | $8,721,000 | +137.2% | 256,500 | +119.8% | 0.35% | +134.0% |
Q1 2014 | $3,676,000 | – | 116,689 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |